VenomAid Diagnostics ApS: Financial statements 2022
CVR: 39981165
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
VenomAid Diagnostics ApS (CVR 39981165) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 303,628 and a net result of DKK -915,022 compared with DKK -24,048 the year before. That is an increase of 3,836.1% compared with the year before. Equity in the 2022 report amounted to DKK -820,646. The company had 3 employees in the financial year.
- Gross Profit
- DKK 303,628
- Profit/Loss
- DKK -915,022
- Equity
- DKK -820,646
- Total Assets
- DKK 6,699,804
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 304 t. | -915 t. | -821 t. | 3 |
| 2021 | 90 t. | 8 t. | -24 t. | 94 t. | - |
| 2020 | 55 t. | 25 t. | 20 t. | 118 t. | - |
Official annual report
Keep an eye on VenomAid Diagnostics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of August 30, 2022, BAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of VenomAid Diagnostics ApS.
As of August 30, 2022, Mads Aage Laustsen has joined the board of directors of VenomAid Diagnostics ApS.
As of August 30, 2022, Andreas Hougaard Laustsen-Kiel has joined the board of directors of VenomAid Diagnostics ApS.
As of August 30, 2022, Gert Fisker Tomczyk has joined the board of directors of VenomAid Diagnostics ApS.
As of August 30, 2022, Morten Boje Munk has joined the board of directors of VenomAid Diagnostics ApS.
VenomAid Diagnostics ApS has published its annual report for 2021. Revenue came to DKK 90,000, and the net result was DKK -24,048.
About VenomAid Diagnostics ApS
VenomAid Diagnostics ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jonas Arnold Jürgensen-Breum. The board consists of Gert Fisker Tomczyk (chair), Andreas Hougaard Laustsen-Kiel, Mads Aage Laustsen and Morten Boje Munk. The company's owners include LAUSTSEN VENTURES ApS, Moleculo Holdings ApS and Ubia Holdings ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -867,480 and a net result of DKK -3,853,829 compared with DKK -3,694,270 the year before. Equity in the 2025 report amounted to DKK -11,289,971.